Posted by Cheyenne Larson on Mar 18th, 2024
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report) was the target of a large growth in short interest in the month of February. As of February 29th, there was short interest totalling 46,710,000 shares, a growth of...
More of this article »